pioglitazone has been researched along with Adenoma in 3 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Adenoma: A benign epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pioglitazone is a PPARĪ³ agonist commonly prescribed for the clinical treatment of diabetes." | 5.46 | Safety and Preclinical Efficacy of Aerosol Pioglitazone on Lung Adenoma Prevention in A/J Mice. ( Antonides, JD; Galbraith, AR; Haynes, AM; Miller, KA; Miller, WA; O'Sullivan, MG; Ondrey, FG; Seabloom, DE; Steele, VE; Suen, CS; Wuertz, BR, 2017) |
| "Pioglitazone is a PPARĪ³ agonist commonly prescribed for the clinical treatment of diabetes." | 1.46 | Safety and Preclinical Efficacy of Aerosol Pioglitazone on Lung Adenoma Prevention in A/J Mice. ( Antonides, JD; Galbraith, AR; Haynes, AM; Miller, KA; Miller, WA; O'Sullivan, MG; Ondrey, FG; Seabloom, DE; Steele, VE; Suen, CS; Wuertz, BR, 2017) |
| "Treatment with metformin alone and in combination with pioglitazone resulted in statistically significant decreases in lung adenoma formation at both early- and late-stage interventions." | 1.46 | Fixed-Dose Combinations of Pioglitazone and Metformin for Lung Cancer Prevention. ( Antonides, JD; Clapper, ML; Galbraith, AR; Haynes, AM; Miller, KA; Miller, MS; Miller, WA; O'Sullivan, MG; Ondrey, FG; Seabloom, DE; Steele, VE; Wuertz, BR, 2017) |
| "Pioglitazone was of similar potency to rosiglitazone in inhibiting proliferation." | 1.33 | PPAR-gamma expression in pituitary tumours and the functional activity of the glitazones: evidence that any anti-proliferative effect of the glitazones is independent of the PPAR-gamma receptor. ( Bonner, SE; Emery, MN; Galloway, M; Grossman, AB; Korbonits, M; Leontiou, C; Merulli, C; Musat, M; Nanzer, AM; Nikookam, K; Powell, M, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seabloom, DE | 2 |
| Galbraith, AR | 2 |
| Haynes, AM | 2 |
| Antonides, JD | 2 |
| Wuertz, BR | 2 |
| Miller, WA | 2 |
| Miller, KA | 2 |
| Steele, VE | 2 |
| Suen, CS | 1 |
| O'Sullivan, MG | 2 |
| Ondrey, FG | 2 |
| Miller, MS | 1 |
| Clapper, ML | 1 |
| Emery, MN | 1 |
| Leontiou, C | 1 |
| Bonner, SE | 1 |
| Merulli, C | 1 |
| Nanzer, AM | 1 |
| Musat, M | 1 |
| Galloway, M | 1 |
| Powell, M | 1 |
| Nikookam, K | 1 |
| Korbonits, M | 1 |
| Grossman, AB | 1 |
3 other studies available for pioglitazone and Adenoma
| Article | Year |
|---|---|
Safety and Preclinical Efficacy of Aerosol Pioglitazone on Lung Adenoma Prevention in A/J Mice.
Topics: Adenoma; Administration, Inhalation; Aerosols; Animals; Antineoplastic Agents; Chemoprevention; Dose | 2017 |
Fixed-Dose Combinations of Pioglitazone and Metformin for Lung Cancer Prevention.
Topics: Adenoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Chemoprevention; Dose-Response Rel | 2017 |
PPAR-gamma expression in pituitary tumours and the functional activity of the glitazones: evidence that any anti-proliferative effect of the glitazones is independent of the PPAR-gamma receptor.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Animals; Base Sequence; Case-Control Studies; Cell Line, Tu | 2006 |